FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034686952> ?p ?o ?g. }

• W2034686952 endingPage "2579" @default.
• W2034686952 startingPage "2569" @default.
• W2034686952 abstract "Abstract Objective To evaluate the prevalence, clinical associations, and outcome of antiphospholipid syndrome (APS) nephropathy in patients with systemic lupus erythematosus (SLE) and antiphospholipid antibodies (aPL) and in SLE patients without aPL. Methods Kidney biopsy specimens obtained from 81 patients with aPL (18 of whom had APS) and 70 patients without aPL were retrospectively examined for the presence of APS nephropathy. Clinical and serologic data obtained at the time of kidney biopsy and during a mean followup of 7 years were recorded. In cases for which serial kidney biopsy specimens were available, the evolution of APS nephropathy was examined. Results APS nephropathy existed in 39.5% of patients with aPL, compared with only 4.3% of patients without aPL. APS nephropathy was associated with both lupus anticoagulant and anticardiolipin antibodies. Among aPL‐positive SLE patients, APS nephropathy was found in two‐thirds of those with APS and in one‐third of those without APS. A strong association between APS nephropathy and the presence of arterial thrombosis and livedo reticularis was noted. Patients with APS nephropathy had a higher frequency of hypertension and elevated serum creatinine levels at the time of kidney biopsy but did not have a higher frequency of renal insufficiency, end‐stage renal disease, or death at the end of followup. Serial kidney biopsy specimens were available from 11 patients and showed progression of APS nephropathy lesions. During followup, manifestations of APS (especially arterial thromboses) developed more frequently in the SLE/non‐APS patients with APS nephropathy than in those without APS nephropathy. Conclusion Among patients with SLE, APS nephropathy occurs almost exclusively in those with aPL, suggesting an important role of aPL in the pathogenesis of APS nephropathy. Patients with APS nephropathy develop hypertension, raised serum creatinine levels, and progression of histologic lesions, all of which are associated with a poor renal outcome. Manifestations of APS also tend to develop in these patients. APS nephropathy should be included in the APS classification criteria, and the use of appropriate anticoagulant therapy should be tested." @default.
• W2034686952 created "2016-06-24" @default.
• W2034686952 creator A5007040488 @default.
• W2034686952 creator A5042020021 @default.
• W2034686952 creator A5057315838 @default.
• W2034686952 creator A5059993695 @default.
• W2034686952 creator A5073900900 @default.
• W2034686952 date "2004-08-01" @default.
• W2034686952 modified "2023-10-16" @default.
• W2034686952 title "Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long-term outcome" @default.
• W2034686952 cites W1971391512 @default.
• W2034686952 cites W1980784832 @default.
• W2034686952 cites W1985259362 @default.
• W2034686952 cites W1991721757 @default.
• W2034686952 cites W2000356037 @default.
• W2034686952 cites W2027077460 @default.
• W2034686952 cites W2029446580 @default.
• W2034686952 cites W2031161496 @default.
• W2034686952 cites W2041297457 @default.
• W2034686952 cites W2045483283 @default.
• W2034686952 cites W2053289832 @default.
• W2034686952 cites W2054736783 @default.
• W2034686952 cites W2062001372 @default.
• W2034686952 cites W2066735165 @default.
• W2034686952 cites W2075889039 @default.
• W2034686952 cites W2092183001 @default.
• W2034686952 cites W2092282547 @default.
• W2034686952 cites W2092285841 @default.
• W2034686952 cites W2124386898 @default.
• W2034686952 cites W2133550356 @default.
• W2034686952 cites W2135433033 @default.
• W2034686952 cites W2139886079 @default.
• W2034686952 cites W2146203649 @default.
• W2034686952 cites W2171263423 @default.
• W2034686952 cites W2271713358 @default.
• W2034686952 cites W2327141264 @default.
• W2034686952 cites W36275675 @default.
• W2034686952 cites W4296981399 @default.
• W2034686952 doi "https://doi.org/10.1002/art.20433" @default.
• W2034686952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15334471" @default.
• W2034686952 hasPublicationYear "2004" @default.
• W2034686952 type Work @default.
• W2034686952 sameAs 2034686952 @default.
• W2034686952 citedByCount "204" @default.
• W2034686952 countsByYear W20346869522012 @default.
• W2034686952 countsByYear W20346869522013 @default.
• W2034686952 countsByYear W20346869522014 @default.
• W2034686952 countsByYear W20346869522015 @default.
• W2034686952 countsByYear W20346869522016 @default.
• W2034686952 countsByYear W20346869522017 @default.
• W2034686952 countsByYear W20346869522018 @default.
• W2034686952 countsByYear W20346869522019 @default.
• W2034686952 countsByYear W20346869522020 @default.
• W2034686952 countsByYear W20346869522021 @default.
• W2034686952 countsByYear W20346869522022 @default.
• W2034686952 countsByYear W20346869522023 @default.
• W2034686952 crossrefType "journal-article" @default.
• W2034686952 hasAuthorship W2034686952A5007040488 @default.
• W2034686952 hasAuthorship W2034686952A5042020021 @default.
• W2034686952 hasAuthorship W2034686952A5057315838 @default.
• W2034686952 hasAuthorship W2034686952A5059993695 @default.
• W2034686952 hasAuthorship W2034686952A5073900900 @default.
• W2034686952 hasConcept C126322002 @default.
• W2034686952 hasConcept C134018914 @default.
• W2034686952 hasConcept C2776874634 @default.
• W2034686952 hasConcept C2776912625 @default.
• W2034686952 hasConcept C2778653478 @default.
• W2034686952 hasConcept C2779134260 @default.
• W2034686952 hasConcept C2779912601 @default.
• W2034686952 hasConcept C2780022809 @default.
• W2034686952 hasConcept C2780091579 @default.
• W2034686952 hasConcept C2780868729 @default.
• W2034686952 hasConcept C2781087799 @default.
• W2034686952 hasConcept C2781184683 @default.
• W2034686952 hasConcept C555293320 @default.
• W2034686952 hasConcept C71924100 @default.
• W2034686952 hasConcept C90924648 @default.
• W2034686952 hasConceptScore W2034686952C126322002 @default.
• W2034686952 hasConceptScore W2034686952C134018914 @default.
• W2034686952 hasConceptScore W2034686952C2776874634 @default.
• W2034686952 hasConceptScore W2034686952C2776912625 @default.
• W2034686952 hasConceptScore W2034686952C2778653478 @default.
• W2034686952 hasConceptScore W2034686952C2779134260 @default.
• W2034686952 hasConceptScore W2034686952C2779912601 @default.
• W2034686952 hasConceptScore W2034686952C2780022809 @default.
• W2034686952 hasConceptScore W2034686952C2780091579 @default.
• W2034686952 hasConceptScore W2034686952C2780868729 @default.
• W2034686952 hasConceptScore W2034686952C2781087799 @default.
• W2034686952 hasConceptScore W2034686952C2781184683 @default.
• W2034686952 hasConceptScore W2034686952C555293320 @default.
• W2034686952 hasConceptScore W2034686952C71924100 @default.
• W2034686952 hasConceptScore W2034686952C90924648 @default.
• W2034686952 hasIssue "8" @default.
• W2034686952 hasLocation W20346869521 @default.
• W2034686952 hasLocation W20346869522 @default.
• W2034686952 hasOpenAccess W2034686952 @default.
• W2034686952 hasPrimaryLocation W20346869521 @default.
• W2034686952 hasRelatedWork W2097468114 @default.

• next